Match tier
Listed
Presence
Current · Arkansas
Last published
2022
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
F
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Fabio Ntagwabira's research focuses on understanding the cognitive impairments that can result from chemotherapy treatments. His work has investigated the effects of common chemotherapy drugs, such as docetaxel, doxorubicin, and cyclophosphamide, on cognitive function. Ntagwabira has also explored potential therapeutic interventions, including the use of piperlongumine as a neuro-protectant against chemotherapy-induced cognitive impairment. His methodological approaches include studies on the dissociation of mouse brain hippocampal tissue for cellular analysis. Ntagwabira collaborates with researchers at the University of Arkansas for Medical Sciences, including Antiño R. Allen, Pilar Simmons, Taurean Brown, and Taylor McElroy, with whom he has co-authored multiple publications. His scholarship metrics include an h-index of 4 and 6 total publications.
Metrics
- h-index: 4
- Publications: 6
- Citations: 114
Selected Publications
-
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment (2022)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue (2021)
-
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide (2021)
-
Cranial irradiation impairs juvenile social memory and modulates hippocampal physiology (2020)
-
Long-Term Changes in Cognition and Physiology after Low-Dose 16O Irradiation (2019)
Collaboration Network
Top Collaborators
Taurean Brown
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Taylor McElroy
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Pilar Simmons
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Antiño R. Allen
University of Arkansas for Medical Sciences
4 shared publications
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Madison Trujillo
University of Arkansas for Medical Sciences (US)
3 shared publications
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
- Combined Mechanical and Enzymatic Dissociation of Mouse Brain Hippocampal Tissue
Huddoy Walters
University of Arkansas for Medical Sciences (US)
1 shared publication
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Jing Wang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Stephanie D. Byrum
University of Arkansas for Medical Sciences
1 shared publication
In database
- Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide
Delawerence Sykes
Pomona College (US)
1 shared publication
- Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Similar Researchers
Based on overlapping research topics
Thomas Groves
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Taurean Brown
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Cancer Treatment and Pharmacology
Neuroscience and Neuropharmacology Research
Pilar Simmons
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Cancer Treatment and Pharmacology
Neuroscience and Neuropharmacology Research
Mathew Newman
Arkansas State University
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications
Antiño R. Allen
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Cancer Treatment and Pharmacology
Neuroscience and Neuropharmacology Research
James C. Fuscoe
National Center for Toxicological Research
Cancer Treatment and Pharmacology
Pharmacological Effects and Toxicity Studies
Molecular Biology Techniques and Applications